Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Merck & Co. News

Home | Index > Business & Companies > Dow Components > Merck & Co.

TAKE THIS POLL
Will the world economy start to recover from the current economic crisis in 2009? (Dec. 28, 2008) Yes. Not yet. Don't know.

Stocks fall despite economy hopes 5 Jan 2009 22:30 GMT
... (INTC) $14.91 -1.91% Caterpillar Inc. (CAT) $46.08 -1.77% Walt Disney-Disney C (DIS) $23.50 -1.76% Merck Co Inc. (MRK) $30.53 -1.52% Nasdaq 100 - Risers Wynn Resorts Ltd. (WYNN) $52.30 +10.29% Foster ...
Merck to Hold Fourth-Quarter 2008 Sales and Earnings Conference Call on Feb. 3 5 Jan 2009 21:50 GMT
... WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck & Co., Inc. will hold its fourth-quarter 2008 sales and earnings conference call with institutional investors ...
Research and Markets: South Africa Pharmaceuticals and Healthcare Report Q4 2008 - Between 2008 and 2012, it is Forecasted that the Average Drug Expenditure Growth will be 10.3% a Year 5 Jan 2009 18:30 GMT
... Capital for an undisclosed sum. -- Sanofi-Aventis -- Pfizer -- Roche -- GlaxoSmithKline -- Merck & Co -- Aspen Pharmacare -- Adcock Ingram -- Enaleni Pharmaceuticals ...
Merck Stops Producing Vaccines Without Cells From Babies Killed in Abortions 5 Jan 2009 16:56 GMT
... babies killed in abortions is worried about a new decision from the pharmaceutical giant Merck. The company has decided to stop producing some vaccines that are not made based on fetal ...
PPD buys Merck facility, enters testing contract 5 Jan 2009 16:31 GMT
... PPD buys Merck facility, enters testing contract The Associated Press | 05 Jan 2009 | 10:15 AM ET ...

PPD buys Merck vaccine facility, will provide testing services for 5 years under contract 5 Jan 2009 15:51 GMT
... Drug development contractor PPD Inc. said Monday it bought a vaccine testing laboratory from Merck & Co. as part of a partnership to provide the drug developer with testing services over the ...
Merck sells vaccine lab to PPD in research deal 5 Jan 2009 15:32 GMT
... (Reuters) - Pharmaceutical Product Development ( ), a large contract research company, has purchased Merck & Co's ( ) vaccine testing laboratory as part of a collaboration with the drugmaker, PPD ...
Research and Markets: Turkey Pharmaceuticals and Healthcare Report Q4 2008 Highlights High Forecast Growth and the Strengthening of Economic and Political Ties with Europe 5 Jan 2009 15:20 GMT
... Co-operation 29 Research And Development Sector 29 Novartis Sanofi-Aventis GlaxoSmithKline Pfizer Roche AstraZeneca Bayer Merck & Co Abdi Ibrahim Eczacibai Pharmaceuticals Sanovel Pharmaceuticals EastPharma (formerly Deva Holding) Actavis (formerly Fako) Biomeks Research ...
Research and Markets: Egypt Pharmaceuticals and Healthcare Report Q4 2008 Indicates Rapid Population Increase Is A Major Hindrance To Egypt's Plans For Free Healthcare 5 Jan 2009 15:13 GMT
... -- GlaxoSmithKline (GSK) -- Sanofi-Aventi -- Pfizer -- Novartis -- Bristol-Myers Squibb (BMS) -- Merck & Co -- AstraZeneca -- Egyptian International Pharmaceutical Industries Co (EIPICO -- SEDICO -- Alexandria Pharmaceuticals -- ...
Schering - Plough spent $500,000 lobbying federal government in third quarter 5 Jan 2009 14:52 GMT
... an unfavorable study on the cholesterol drug Vytorin, which it sells jointly with partner Merck & Co. Schering-Plough also lobbied on proposals that would give shareholders a voice in compensation decisions for ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

Schering-Plough spent $500K lobbying in 3Q 5 Jan 2009 14:51 GMT
... an unfavorable study on the cholesterol drug Vytorin, which it sells jointly with partner Merck & Co. Schering-Plough also lobbied on proposals that would give shareholders a voice in compensation decisions for ...
UPDATE 1-Merck sells vaccine lab to PPD in research deal 5 Jan 2009 14:49 GMT
... (Reuters) - Pharmaceutical Product Development ( ), a large contract research company, has purchased Merck & Co's ( ) vaccine testing laboratory as part of a collaboration with the drugmaker, PPD ...
Merck Serono: Study Published in JCO Shows Erbitux Enhances Efficacy in mCRC Patients with KRAS Wild-Type Tumors in 1st-Line Setting 5 Jan 2009 14:47 GMT
... Dr Frank T. Weber, Senior Vice President and Head of Medical Science and Innovation, Merck Serono. “The enhanced efficacy that Erbitux provides patients with KRAS wild-type tumors in the 1st-line ...
New Report on Global Ophthalmic Market: Focus on Glaucoma by Koncept Analytics 5 Jan 2009 14:12 GMT
... the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players. The report broadly includes the following 1. Glaucoma: An Introduction 2. ...
PPD Enters Into Strategic Collaboration with Merck 5 Jan 2009 13:50 GMT
... PPD Enters Into Strategic Collaboration with Merck )--PPD, Inc. (Nasdaq: PPDI) today announced it has entered into a strategic collaboration with Merck ...
Koncept Analytics Releases New Report on Global Ophthalmic Market Focus on Glaucoma 5 Jan 2009 13:31 GMT
... the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players. The report broadly includes the following: 1. Glaucoma: An Introduction 2. ...
Idera Pharmaceuticals Announces Publication of Studies on Chemistry of Novel Antagonists for Toll-like Receptors 7 and 9 5 Jan 2009 13:31 GMT
... approval, they will be successfully distributed and marketed; whether the Company's collaborations with Novartis, Merck & Co., Inc. and Merck KGaA will be successful; whether the patents and patent applications owned ...
Research and Markets: Qatar Pharmaceuticals and Healthcare Report Q4 2008 out Now 5 Jan 2009 13:30 GMT
... Qatar Business Environment SWOT -- Pharmaceutical Business Environment Ratings -- Table -- Novartis -- Merck & Co -- Wyeth -- Qatari German Company For Medical Devices -- Care Holding -- Ebn Sina ...
Koncept Analytics Releases New Report on Global Ophthalmic Market Focus on Glaucoma 5 Jan 2009 13:30 GMT
... the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players. The report broadly includes the following: 1. Glaucoma: An Introduction 2. ...
Merck Serono: Study Published in JCO Shows Erbitux Enhances Efficacy in mCRC Patients with KRAS Wild-Type Tumors in 1st-Line Setting 5 Jan 2009 13:10 GMT
... Merck Serono: Study Published in JCO Shows Erbitux Enhances Efficacy in mCRC Patients with KRAS Wild-Type ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Idera Pharmaceuticals Announces Publication of Studies on Chemistry of Novel Antagonists for Toll-like Receptors 7 and 9 5 Jan 2009 12:50 GMT
... approval, they will be successfully distributed and marketed; whether the Company's collaborations with Novartis, Merck & Co., Inc. and Merck KGaA will be successful; whether the patents and patent applications owned ...
Pharmaceutical award curious 5 Jan 2009 10:14 GMT
... who has been following the saga of Merck & Co. Inc. One can only speculate ... squeaky-clean. In 2004, its top-selling arthritis drug, Vioxx, was pulled from the shelves by the FDA due ...
New Services from eCareerCenter Simplify Online Job Searching 4 Jan 2009 20:50 GMT
... go online for unbiased assistance on what really works. recruiter. After events took his Merck & Co., Inc. job down to temporary recruiting, Jeff realized something important that would change his ...
Ambrilia Biopharma prÃ©sente une requÃªte d'arbitrage Ã l'encontre de Merck 4 Jan 2009 16:12 GMT
... Ambrilia Biopharma présente une requête d'arbitrage à l'encontre de Merck MONTREAL, QUEBEC - (Marketwire - 30 déc. 2008) - Ambrilia Biopharma inc. (TSX:AMB) annonce aujourd'hui ...
What stocks will be '09 winners and losers? 4 Jan 2009 06:30 GMT
... a worldwide franchise and people will always want to be entertained. Pharmaceuticals: Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co. have cash to team up with biotech firms for new drug ...